Literature DB >> 11801630

Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis.

Rebecca J Greenwald1, Alexander J McAdam, Diane Van der Woude, Abhay R Satoskar, Arlene H Sharpe.   

Abstract

The CD28 family member inducible costimulator protein (ICOS) has an important role in T cell differentiation and Ig class switching. To investigate the role of ICOS in vivo, ICOS-/- mice were infected s.c. with Leishmania mexicana. While wild-type mice developed large, cutaneous lesions, the growth of lesions and tissue histopathology was significantly delayed in ICOS-/- mice. ICOS-/- mice exhibited marked decreases in both Th1 and Th2 cytokine production and profound defects in L. mexicana-specific Ig isotype class switching to IgG1 and IgG2a and reduced total IgE levels. Our findings indicate that ICOS is a key regulator of both Th1 and Th2 responses and has a role in controlling cutaneous L. mexicana infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801630     DOI: 10.4049/jimmunol.168.3.991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.

Authors:  Hiroshi Harada; Alan D Salama; Masayuki Sho; Atsushi Izawa; Sigrid E Sandner; Toshiro Ito; Hisaya Akiba; Hideo Yagita; Arlene H Sharpe; Gordon J Freeman; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

3.  T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.

Authors:  Tania H Watts; Edward M Bertram; Jacob Bukczynski; Tao Wen
Journal:  Can J Infect Dis       Date:  2003-07

4.  Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection.

Authors:  P'ng Loke; Xingxing Zang; Lisa Hsuan; Rebecca Waitz; Richard M Locksley; Judith E Allen; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

5.  Modulation of surgical fibrosis by microbial zwitterionic polysaccharides.

Authors:  Begonia Ruiz-Perez; Doo R Chung; Arlene H Sharpe; Hideo Yagita; Wiltrud M Kalka-Moll; Mohamed H Sayegh; Dennis L Kasper; Arthur O Tzianabos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

6.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells.

Authors:  Gusheng Tang; Qin Qin; Peng Zhang; Guifang Wang; Menglei Liu; Qingli Ding; Yanghua Qin; Qian Shen
Journal:  Cell Mol Life Sci       Date:  2009-07-15       Impact factor: 9.261

8.  CD3+ICOS+ T cells show differences in the synthesis of nitric oxide, IFN-γ, and IL-10 in patients with pulmonary tuberculosis or in healthy household contacts.

Authors:  Carmen Lara-Rodríguez; Noé Alvarado-Vásquez; Demetrio Bernal; Patricia Gorocica; Edgar Zenteno; Ricardo Lascuraín
Journal:  Clin Exp Med       Date:  2015-08-08       Impact factor: 3.984

9.  The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells.

Authors:  Aurelie T Bauquet; Hulin Jin; Alison M Paterson; Meike Mitsdoerffer; I-Cheng Ho; Arlene H Sharpe; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-12-21       Impact factor: 25.606

10.  Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Cristina M Lu; Elaine B Brooks; Richard E Fichtl; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.